Skip to main content
Equibles

TUDOR INVESTMENT CORP ET AL

Position in TGTX — Tg Therapeutics, Inc.

CIK 923093 STAMFORD, CT
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,159,964
+$2,280,050 QoQ
Shares Held
93,920
-2.8% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#92
of 426 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Derivatives in TGTX

reported options exposure · as of Jun 30, 2026
CallValue
$351,616
CallShares
6,400
PutValue
$3,999,632
PutShares
72,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. TGTX ranks #17 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 943,287 $66,643,226
2 RPRX
Royalty Pharma plc
 610,736 $34,243,967
3 XENE
Xenon Pharmaceuticals Inc.
 545,387 $32,919,559
4 ABVX
Abivax S.A.
 187,335 $24,964,262
5 INSM
INSMED Inc
 195,391 $20,832,588
6 MLYS
Mineralys Therapeutics, Inc.
 738,370 $19,921,222
7 ABCL
AbCellera Biologics Inc.
 2,063,191 $16,196,049
8 QURE
uniQure N.V.
 328,889 $15,148,627

All Filings in TGTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,999,632 72,800
2026-06-30 $351,616 6,400
2026-06-30 $5,159,964 93,920
2025-12-31 $2,879,914 96,609
2025-09-30 $2,748,462 76,082
2025-09-30 $588,837 16,300
2025-06-30 $251,930 7,000
2025-06-30 $403,088 11,200
2025-03-31 $3,330,849 84,475
2024-06-30 $1,478,206 83,092
2024-03-31 $2,349,884 154,496
2023-12-31 $714,541 41,835
2023-09-30 $791,357 94,660
2022-09-30 $265,458 44,841
2021-09-30 $509,184 15,300
2021-06-30 $768,972 19,824
2020-12-31 $831,435 15,983
2020-03-31 $159,014 16,160